GlassScriptPhysician profile
Ashley J Rossman
NPI 1396184776
$4,911.27
in general payments reported to CMS, 2019-2025
22 companies · $1,908 in 2025
The $1,908 reported for 2025 was more than what 88% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $486 · 2020: $338 · 2021: $344 · 2022: $402 · 2023: $450 · 2024: $983 · 2025: $1,908.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,341.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,841.66 | 2019-2025 | Hydrus Microstent, Clareon, Unity |
| Biotissue Holdings INC. | $823.28 | 2020-2025 | |
| Amgen INC. | $452.87 | 2024-2025 | Tepezza |
| Glaukos Corporation | $370.62 | 2019-2023 | |
| Johnson & Johnson Surgical Vision, INC. | $279.72 | 2019-2025 | Tecnis Iol |
| Ocular Therapeutix, INC. | $276.17 | 2022-2025 | Dextenza |
| Allergan, INC. | $124.83 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $108.45 | 2024-2025 | Xdemvy |
| Kala Pharmaceuticals, INC. | $104.41 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $89.26 | 2024-2025 | Envista Envy Iol, Xiidra, Miebo |
| Horizon Therapeutics Plc | $79.63 | 2022-2023 | Tepezza |
| Carl Zeiss Meditec, INC. | $64.71 | 2019 | |
| Oyster Point Pharma, INC. | $64.23 | 2023-2024 | Tyrvaya, Ryzumvi |
| Shire North American Group INC | $39.05 | 2019 | |
| Dompe US, INC. | $36.04 | 2025 | Oxervate |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $33.90 | 2019-2020 | |
| Sight Sciences, INC. | $29.81 | 2022-2024 | Omni Surgical System |
| Rayner Intraocular Lenses Limited | $27.26 | 2024 | Rayone Spheric, Omidria, Rayone Aspheric |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $19.93 | 2025 | |
| Lombart Brothers, INC. | $19.47 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $13.66 | 2019 | |
| Aerie Pharmaceuticals, INC. | $12.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Rossman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.